Is HUMDF or DGRO a better dividend investment in 2026?

HUMDF currently yields 484.14% with a 5% 5-year dividend growth rate. DGRO yields 2.13% with 9.5% growth. The better choice depends on your goal: HUMDF offers higher current income.

What is the dividend yield difference between HUMDF and DGRO?

HUMDF has a forward dividend yield of 484.14% ($2.00/share annually). DGRO yields 2.13% ($1.47/share annually). The yield gap is 482.01 percentage points.

Home › Compare › HUMDF vs DGRO

HUMDF vs DGRO: Dividend Comparison 2026

HUMDF yields 484.14% · DGRO yields 2.13%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 HUMDF wins by $47899.98M in total portfolio value

INVESTMENT

TIME HORIZON10 years

HUMDF

● Live price

484.14%

Share price

$0.41

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$47900.01M

Annual income

$34,060,653,223.60

Full HUMDF calculator →

DGRO

iShares Core Dividend Growth ETF

● Live price

2.13%

Share price

$68.98

Annual div

$1.47

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$31.6K

Annual income

$239.96

Full DGRO calculator →

Portfolio growth — HUMDF vs DGRO

📍 HUMDF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	HUMDF	DGRO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, HUMDF + DGRO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

HUMDF pays

DGRO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HUMDF

Annual income on $10K today (after 15% tax)

$41,152.26/yr

After 10yr DRIP, annual income (after tax)

$28,951,555,240.06/yr

DGRO

Annual income on $10K today (after 15% tax)

$181.24/yr

After 10yr DRIP, annual income (after tax)

$203.97/yr

At 15% tax rate, HUMDF beats the other by $28,951,555,036.09/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HUMDF + DGRO for your $10,000?

HUMDF: 50%DGRO: 50%

100% DGRO50/50100% HUMDF

Portfolio after 10yr

$23950.02M

Annual income

$17,030,326,731.78/yr

Blended yield

71.11%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HUMDF buys

DGRO buys

No recent congressional trades found for HUMDF or DGRO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricHUMDFDGRO

Forward yield	484.14% ✓	2.13%
Annual dividend / share	$2.00 ✓	$1.47
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$47900.01M ✓	$31.6K
Annual income after 10y	$34,060,653,223.60 ✓	$239.96
Total dividends collected	$46687.76M ✓	$2.3K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: HUMDF vs DGRO ($10,000, DRIP)

Year	HUMDF Portfolio	HUMDF Income/yr	DGRO Portfolio	DGRO Income/yr	Gap
1← crossover	$59,114	$48,414.43	$11,293	$213.22	+$47.8K → HUMDF
2	$330,728	$267,475.81	$12,730	$217.32	+$318.0K → HUMDF
3	$1,752,431	$1,398,551.73	$14,326	$221.10	+$1.74M → HUMDF
4	$8,800,812	$6,925,711.29	$16,098	$224.56	+$8.78M → HUMDF
5	$41,922,789	$32,505,919.38	$18,064	$227.74	+$41.90M → HUMDF
6	$189,569,894	$144,712,509.91	$20,246	$230.65	+$189.55M → HUMDF
7	$814,403,207	$611,563,420.90	$22,666	$233.30	+$814.38M → HUMDF
8	$3,326,842,984	$2,455,431,552.18	$25,349	$235.73	+$3326.82M → HUMDF
9	$12,933,979,587	$9,374,257,594.32	$28,325	$237.94	+$12933.95M → HUMDF
10	$47,900,011,382	$34,060,653,223.60	$31,624	$239.96	+$47899.98M → HUMDF

HUMDF vs DGRO: Complete Analysis 2026

HUMDF — Stock

Hua Medicine (Shanghai) Ltd. operates as a clinical-stage drug development company that focuses on therapies for the treatment of diabetes in China. It develops Dorzagliatin or HMS5552, an oral drug for the treatment of Type 2 Diabetes (T2D); and Dorzagliatin in combination with Metformin, Sitagliptin, and Empagliflozin that is in Phase I clinical trial for treatment of T2D. The company also offers Dorzagliatin in combination with Pioglitazone for NASH; in combination with GLP-1 for Alzheimer diseases; and in combination with late stage T2D and Type 1 Diabetes. In addition, it is developing mGLUR5 for the treatment of Parkinson's disease levodopa-induced dyskinesia. The company was incorporated in 2011 and is based in Beijing, China.

Full HUMDF Calculator →

DGRO — ETF

The iShares Core Dividend Growth ETF seeks to track the investment results of an index composed of U.S. equities with a history of consistently growing dividends.

Full DGRO Calculator →

📬

Get this HUMDF vs DGRO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HUMDF vs SCHD HUMDF vs JEPI HUMDF vs O HUMDF vs KO HUMDF vs MAIN HUMDF vs VIG HUMDF vs NOBL HUMDF vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.